Facet browsing currently unavailable
Page 5 of 3760 results
Sort by: relevance publication year
It's a Free for All—Insulin-Positive Cells Join the Group of Potential Progenitors for Pancreatic Ductal Adenocarcinoma JOURNAL ARTICLE published November 2009 in Cancer Cell |
More Rules, Still Exceptions: Understanding Immunomodulatory Antibody Activity In Vivo JOURNAL ARTICLE published April 2018 in Cancer Cell |
Proteasome Inhibitors Evoke Latent Tumor Suppression Programs in Pro-B MLL Leukemias through MLL-AF4 JOURNAL ARTICLE published April 2014 in Cancer Cell |
The Role of Cdk5 in Neuroendocrine Thyroid Cancer JOURNAL ARTICLE published October 2013 in Cancer Cell |
The Immune Revolution: A Case for Priming, Not Checkpoint JOURNAL ARTICLE published April 2018 in Cancer Cell Research funded by NIH (R01 CA169123,P01 CA210944,P30 CA016520) |
Dysregulated IL-18 Is a Key Driver of Immunosuppression and a Possible Therapeutic Target in the Multiple Myeloma Microenvironment JOURNAL ARTICLE published April 2018 in Cancer Cell Research funded by Cure Cancer Australia and Cancer Australia (1139523,1122183) | National Health and Medical Research Council (1107417,1124690,1132519) | Austrian Science Fund (J-3635) | EMBO (ALT945-2015) | DFG (EXC 1023) | NCI (CA190045,CA186781) | Institut National Du Cancer (PLBIO 16) |
Sequential Therapy with PARP and WEE1 Inhibitors Minimizes Toxicity while Maintaining Efficacy JOURNAL ARTICLE published June 2019 in Cancer Cell Research funded by NIH (CA217842,CA217685,CA098258,CA210950,HG008100) | Komen Foundation (SAC110052) | Breast Cancer Research Foundation (BCRF-17-108) | CPRIT (RP170640,RR160021,FG-2018-10723) | CCSG (CA016672) | Susan G. Komen grant (PDF17483544) |
MEK inhibition overcomes chemoimmunotherapy resistance by inducing CXCL10 in cancer cells JOURNAL ARTICLE published February 2022 in Cancer Cell |
The Architecture and Evolution of Cancer Neochromosomes JOURNAL ARTICLE published November 2014 in Cancer Cell |
Data Triumph at C JOURNAL ARTICLE published April 2017 in Cancer Cell Research funded by Marcus Foundation (NCT02516670) |
Cancer and Apoptosis: Who Is Built to Last? JOURNAL ARTICLE published January 2017 in Cancer Cell |
Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex JOURNAL ARTICLE published April 2004 in Cancer Cell |
Head of the Class: OLIG2 and Glioblastoma Phenotype JOURNAL ARTICLE published May 2016 in Cancer Cell Research funded by NIH (R01NS096238) |
Recurrent DGCR8, DROSHA, and SIX Homeodomain Mutations in Favorable Histology Wilms Tumors JOURNAL ARTICLE published March 2015 in Cancer Cell |
Determinants of Oncogenic Transformation in Acute Promyelocytic Leukemia: The Hetero-Union Makes the Force JOURNAL ARTICLE published July 2007 in Cancer Cell |
Pancreatic Cancer: Planning Ahead for Metastatic Spread JOURNAL ARTICLE published June 2016 in Cancer Cell |
Human C-Reactive Protein Binds Activating Fcγ Receptors and Protects Myeloma Tumor Cells from Apoptosis JOURNAL ARTICLE published September 2007 in Cancer Cell |
Olig2-Dependent Reciprocal Shift in PDGF and EGF Receptor Signaling Regulates Tumor Phenotype and Mitotic Growth in Malignant Glioma JOURNAL ARTICLE published May 2016 in Cancer Cell Research funded by NIH (R01 NS078092,R01 NS075243) |
T cell engagers in solid tumors kick the door down JOURNAL ARTICLE published November 2021 in Cancer Cell |
The new kid on the block(ade) of the IGF-1 receptor JOURNAL ARTICLE published March 2004 in Cancer Cell |